Compass Pathways Announces First Quarter 2024 Financial
COMP360 phase 3 pivotal program in treatment-resistant depression (TRD) on track for top-line COMP005 trial data in fourth quarter 2024, ...
Read moreCOMP360 phase 3 pivotal program in treatment-resistant depression (TRD) on track for top-line COMP005 trial data in fourth quarter 2024, ...
Read moreLONDON, May 03, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access ...
Read moreManthan School recently hosted their University Fair that saw over 20 prestigious universities and colleges in India taking part, ...
Read moreLONDON, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating patient ...
Read moreUK sites to participate in part of pivotal phase 3 program following Medicines and Healthcare Regulatory Agency approval of study ...
Read moreGEAPP is an alliance of 20+ partners working to unlock renewable energy access in emerging economies. ...
Read more© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.
© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.